Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alloksys Life Sciences

Alloksys Life Sciences
2005 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of drug development services intended to develop innovative drug therapies for treatment of patients. The company's drug development therapy include EP 2 252 324 B1, US 8784805 B2 which increase the activity of the immune system of inflammatory diseases, enabling the medical sector to get access to innovative drug therapies.

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • AgroBusiness Park 10
  • 6708 PW Wageningen
  • Netherlands

+31 0317 000 000

Alloksys Life Sciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Alloksys Life Sciences‘s full profile, request access.

Request full access to PitchBook

Alloksys Life Sciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Alloksys Life Sciences‘s full profile, request access.

Request full access to PitchBook

Alloksys Life Sciences Executive Team (4)

Name Title Board
Seat
Contact
Info
Koos Haasteren Chief Executive Officer
Ruud Brands Ph.D Founder & President
Herman Feil Ph.D Chief Financial Officer
Willem Seinen Ph.D Chief Scientific Officer